These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36310193)

  • 1. Preparation and Investigation of Crucial Oligomers in the Early Stages of Aβ40 and Aβ42 Aggregation.
    Morel B; Conejero-Lara F
    Methods Mol Biol; 2023; 2551():15-28. PubMed ID: 36310193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic micellar oligomers of amyloid beta peptides play a crucial role in their aggregation mechanisms.
    Morel B; Carrasco MP; Jurado S; Marco C; Conejero-Lara F
    Phys Chem Chem Phys; 2018 Aug; 20(31):20597-20614. PubMed ID: 30059119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ; Chen YR
    FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions.
    Gu L; Guo Z
    Biochem Biophys Res Commun; 2021 Jan; 534():292-296. PubMed ID: 33272573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Conversion of Amyloid-Beta 1-40 Oligomers to Mature Fibrils through a Self-Catalytic Bimolecular Process.
    Morel B; Carrasco-Jiménez MP; Jurado S; Conejero-Lara F
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
    Wang L; Eom K; Kwon T
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Molecule Characterization of Heterogeneous Oligomer Formation during Co-Aggregation of 40- and 42-Residue Amyloid-β.
    Meng F; Kim JY; Louis JM; Chung HS
    J Am Chem Soc; 2024 Sep; 146(35):24426-24439. PubMed ID: 39177153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and Fractionation of Heterogeneous Aβ42 Oligomers with Different Aggregation Properties.
    Chen EW; Guo Z
    Methods Mol Biol; 2023; 2551():29-39. PubMed ID: 36310194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer's disease.
    Ghosh P; Kumar A; Datta B; Rangachari V
    BMC Bioinformatics; 2010 Oct; 11 Suppl 6(Suppl 6):S24. PubMed ID: 20946608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of co-oligomer formation by amyloid-beta peptide isoforms.
    Iljina M; Garcia GA; Dear AJ; Flint J; Narayan P; Michaels TC; Dobson CM; Frenkel D; Knowles TP; Klenerman D
    Sci Rep; 2016 Jun; 6():28658. PubMed ID: 27346247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
    Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms.
    Coskuner O; Wise-Scira O; Perry G; Kitahara T
    ACS Chem Neurosci; 2013 Feb; 4(2):310-20. PubMed ID: 23421682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of a Well-Defined and Stable β-Barrel Pore-Forming Aβ42 Oligomer.
    Serra-Batiste M; Ninot-Pedrosa M; Puig E; Ciudad S; Gairí M; Carulla N
    Methods Mol Biol; 2018; 1779():13-22. PubMed ID: 29886524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mimotope of Aβ oligomers may also behave as a β-sheet inhibitor.
    Zhang YX; Wang SW; Lu S; Zhang LX; Liu DQ; Ji M; Wang WY; Liu RT
    FEBS Lett; 2017 Nov; 591(21):3615-3624. PubMed ID: 28976547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and Characterization of Zn(II)-Stabilized Aβ
    González Díaz A; Cataldi R; Mannini B; Vendruscolo M
    ACS Chem Neurosci; 2024 Jul; 15(14):2586-2599. PubMed ID: 38979921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
    Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
    Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Models of Quasi-Stable Amyloid β40 Oligomers with Significant Neurotoxicity.
    Irie Y; Murakami K; Hanaki M; Hanaki Y; Suzuki T; Monobe Y; Takai T; Akagi KI; Kawase T; Hirose K; Irie K
    ACS Chem Neurosci; 2017 Apr; 8(4):807-816. PubMed ID: 28026168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of pure populations of covalently stabilized amyloid β-protein oligomers of specific sizes.
    Hayden EY; Conovaloff JL; Mason A; Bitan G; Teplow DB
    Anal Biochem; 2017 Feb; 518():78-85. PubMed ID: 27810329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EPR Studies of Aβ42 Oligomers Indicate a Parallel In-Register β-Sheet Structure.
    Jang C; Portugal Barron D; Duo L; Ma C; Seabaugh H; Guo Z
    ACS Chem Neurosci; 2024 Jan; 15(1):86-97. PubMed ID: 38109787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural differences between amyloid beta oligomers.
    Breydo L; Kurouski D; Rasool S; Milton S; Wu JW; Uversky VN; Lednev IK; Glabe CG
    Biochem Biophys Res Commun; 2016 Sep; 477(4):700-705. PubMed ID: 27363332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.